Outcomes4Me
PrivateLast Round
Series A
May 29, 2025
Total Funding Raised
$37.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Outcomes4Me is a healthtech company that provides an AI-driven, direct-to-patient platform for cancer care, offering personalized treatment options, clinical trial matching, and symptom management.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Outcomes4Me Comparables
Compare Outcomes4Me with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Belong.Life | 81% | |
| Jasper Health | 78% | |
| OncoPower | 77% |
Outcomes4Me Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 29, 2025 | ||||
| Series A | Apr 28, 2021 | ||||
| Seed | Nov 18, 2020 |
Outcomes4Me Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Seed |
| Sierra Ventures | Series A, Seed |
| Salica Investments | Series A |
| Salica Investments | Series A |
| Asset Management Ventures | Series A, Seed |
| Northpond Ventures | Series A |
| Hambro Perks Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 60% MoM.
- Oct 10, 2025
Launched a cancer-focused app incorporating NCCN guidelines.
Recent news
Latest coverage and updates
- recognized_asSep 14, 2026
Outcomes4Me Inc. recognized as nominee for "Best Startup.
- recognized_asSep 14, 2026
Outcomes4Me Inc. recognized as Best Inventions of 2025.
- recognized_asSep 14, 2026
Outcomes4Me Inc. recognized as Inc. 5000 list of fastest-growing private companies.
- hiresSep 14, 2026
Outcomes4Me Inc. hired Jim as Chief Revenue Officer on Sep 14th '26.
- hiresSep 14, 2026
Outcomes4Me Inc. hired Jim Longley as Chief Revenue Officer on Sep 14th '26.
Outcomes4Me Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Outcomes4Me's valuation, stock price, and market status.
Is Outcomes4Me a public or private company?
Outcomes4Me is a private company.
What is the current stock price of Outcomes4Me?
Outcomes4Me is a private company with no public stock price. No recent secondary market data is available.
How much is Outcomes4Me worth (valuation)?
Valuation information for Outcomes4Me is not publicly available.
Can I buy Outcomes4Me stock?
Outcomes4Me shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Outcomes4Me's last funding round?
Outcomes4Me's most recent funding round was Series A on May 29, 2025.
Who are the main investors in Outcomes4Me?
Key investors in Outcomes4Me include Salica Investments, Asset Management Ventures, Northpond Ventures, Hambro Perks Ltd..
Will Outcomes4Me IPO soon?
No public IPO plans have been announced for Outcomes4Me.
How can I track Outcomes4Me secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Outcomes4Me's secondary market activity and sign up for updates.